Arch Therapeutics Will Present at the 2016 Bio Investor Forum in San Francisco, California October 18-19th, 2016

FRAMINGHAM, MA (Marketwired Oct 11, 2016) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of AC5™ devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, today announced that it will be featured as a presenting company at the BIO Investor Forum taking place from October 18-19, 2016 at the Westin St. Francis Hotel in San Francisco, California. Terrence W. Norchi, MD, CEO is scheduled to present
http://bit.ly/2dIJSnD